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Abstract 
Evidence that multiple, probably non-endocytic mechanisms are involved in the uptake into mammalian cells of the t~- 
helical amphipathic model peptide FLUOS-KLALKLALKALKAALKLA-NH2 (I) is presented. Extensive cellular uptake 
of N-terminally GC-elongated derivatives of I, conjugated by disufide bridges to differently charged peptides, indicated that 
I-like model peptides might serve as vectors for intracellular delivery of polar bioactive compounds. The mode of the cellular 
internalization of I comprising energy-, temperature-, pH- and ion-dependent as well as -independent processes suggests 
analogy to that displayed by small unstructured peptides reported previously (Oehlke et al., Biochim. Biophys. Acta 1330 
(1997) 50-60). The uptake behavior of I also showed analogy to that of several protein-derived helical peptide sequences, 
recently found to be capable of efficiently carrying tagged oligonucleotides and peptides directly into the cytosol of 
mammalian cells (Derossi et al., J. Biol. Chem. 269 (1994) lOA.A. A. -10450; Lin et al., J. Biol. Chem. 270 (1995) 14255-14258; 
Fawell et al., Proc. Natl. Acad. Sci. USA 91 (1994) 664-668; Chaloin et al., Biochemistry 36 (1997) 11179-11187; Vives et al., 
J. Biol. Chem., 272 (1997) 16010-16017). © 1998 Elsevier Science B.V. All rights reserved. 
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I. Introduction 
Polar, biologically active compounds, uch as anti- 
Abbreviations: AEC, bovine aortic endothelial cells; CLSM, 
confocal laser scanning microscopy; DNP-SG, S-(2,4-dinitrophe- 
nyl)glutathione; DOG, 2-deoxy-D-glucose; DPBSG, Dulbecco's 
phosphate-buffered saline supplemented with 1 g/1 o-glucose; 
FLUOS, 5(6)-carboxyfluoresceinyl; NEM, N-ethylmaleimide; 
PBS, phosphate-buffered saline 
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sense oligonucleotides and peptides capable of block- 
ing associations between signal transducing proteins, 
are becoming increasingly interesting as pharmaco- 
logical probes and potential drugs. The applicability 
of such compounds, however, is severely impaired by 
inefficient delivery to their sites of action within the 
cell. Most approaches currently applied to translo- 
cate such compounds across plasma membranes 
rely on endocytic mechanisms [1]. An endocytic 
mode of uptake, however, poses problems in that 
the quantity of transported substrates and particu- 
larly the rate of their liberation from endosomes 
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are limited; sufficient concentrations at the target 
sites in cytosol or nucleus are, therefore, difficult to 
achieve [1,2]. 
As promising alternatives, non-endocytic translo- 
cation approaches have been presented recently by 
several authors, based on the use of protein derived 
vector peptides [3-7]. These natural peptides proved 
capable of translocating covalently tagged, mem- 
brane-impermeable p ptides and oligonucleotides 
across the plasma membrane directly into the cyto- 
sol. The actual mechanism of entry of these peptides 
and their conjugates remains unclear. A non-endo- 
cytic mode of the cellular uptake is indicated by the 
observation of efficient ranslocation across the plas- 
ma membrane ven at 0°C [3]. 
Recently, we reported on the internalization i to 
endothelial cells of a simple helical amphipathic 
model peptide, FLUOS-KLALKLALKALKAAL- 
KLA-NH2 (I) via a non-endocytic, amphipathicity- 
dependent mechanism, similar to that of the afore- 
mentioned natural peptides [8]. In the present work, 
we further investigate the mode of uptake of this 
model peptide. Our results indicate that multiple 
non-specific, energy-dependent and -independent 
processes are involved in the translocation of I across 
the plasma membrane. Analogy is suggested to the 
cellular uptake of natural membrane permeable pep- 
tide sequences [8] as well as to that of small unstruc- 
tured enkephalin-derived peptides described previ- 
ously [9]. 
2. Materials and methods 
2.1. Materials 
5(6)-Carboxyfluorescein-N-hydroxysuccinimide es- 
ter (FLUOS) was purchased from Boehringer (Mann- 
heim, Germany). 2,4-Dinitrophenyl-S-glutathione 
(DNP-SG) was synthesized according to Hinchman 
et al. [10]. For dialysis Spectra/Por DispoDialyzers 
(cellulose ster, 5 mm diameter, 2 ml sample volume) 
with molecular weight cut-offs of 10 and 50 kDa 
(Sigma, Deisenhofen, Germany) were used. Release 
of lactate dehydrogenase was assessed by means of 
LDH-L reagent from Sigma. Other chemicals and 
reagents, when not specified, were purchased from 
Sigma or Bachem. 
2.1.1. Peptide synthesis 
The peptides were synthesized automatically by 
solid phase methods using standard Fmoc chemistry 
as described previously [11]. To introduce the fluo- 
rescent label, the peptides were N-terminally conju- 
gated with 5(6)-carboxyfluorescein-N-hydroxysucci- 
nimide ester (FLUOS; Boehringer, Mannheim) 
(two equivalents in DMF), and the final cleavage 
was performed with 95% TFA/5% water for 3 h. 
For connecting cysteine tagged vector- and cargo- 
peptides by disulfide bridges, either the vector pep- 
tide (in the case of acidic or neutral cargo peptides) 
or the cargo peptide (when basic) was dissolved in 
water (to 1 mM) and reacted with a 100-fold excess 
of a 100 mM aqueous solution di-Na-5,5'-dithio- 
bis(2-nitrobenzoic a id) (Ellman's reagent) for 5 h 
at 60°C. In the case of activated vector peptides, 
the reaction product was virtually quantitatively cen- 
trifuged off, washed four times with water and dis- 
solved in 1 M NaC1 in ethanol/water 1:1 to a con- 
centration of about 100 ~tM. For the activated basic 
cargo peptides, the reaction solution was acidified to 
about pH 2 with 10% trifluoroacetic acid and ex- 
tracted four times with ethyl acetate. Subsequently, 
an equal amount of ethanol was added. 
To generate the disulfide bonds, a 5-fold excess of 
5 mM aqueous olutions of the SH-group containing 
counterparts were added to the peptides activated 
with Ellman's reagent, allowed to react for 2 h at 
60°C, and HPLC purified. To avoid aggregation of 
the reaction products the reaction mixture was sup- 
plemented with NaC1 and ethanol to 1 M and 50%, 
respectively. The HPLC fractions containing the re- 
action products were also supplemented with NaC1 
up to about 0.1 M and concentrated almost to dry- 
ness by means of a vacuum centrifugal evaporator. 
2.2. Cell culture 
Calf aortic endothelial cells (AEC), 12.-20. sub- 
culture of a cell line (LKB Ez 7), established and 
characterized by Halle et al. [12], were seeded at an 
initial density 5 x 104 cells/cm 2 into 24-well culture 
plates. The cells were cultured at 37°C in a humidi- 
fied 5% CO2 containing air environment in minimal 
essential medium (MEM; Sigma, Deisenhofen) sup- 
plemented with additional 290 mg/1 glutamine and 
10% fetal calf serum (FCS; Sigma, Deisenhofen). 
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After 4 days without replacing the medium, the cells 
were used for the uptake experiments. 
Porcine endothelial cells (SEZ; MEM/5% FCS) 
[13], human umbilical vein endothelial cells (ECV 
304, ATCC no. CRL 1998; M199/10% heat inacti- 
vated FCS), human neuroblastoma cells (SK-N-SH; 
MEM Eagle/10% FCS supplemented with 1% non- 
essential amino acids, 1% Na-pyruvate and 1% glu- 
tamine (Biochrom, Berlin, Germany)), and human 
hepatoma cells (Hep G2; MEM Eagle/10% FBS sup- 
plemented with 1% non-essential mino acids, 1% 
Na-pyruvate and 1% glutamine) were cultured simi- 
larly. 
2.3. Uptake experiments 
After removal of the medium, the cell layers were 
rinsed two times at 37°C with Dulbecco's phosphate- 
buffered saline (DPBS; Biochrom, Berlin) supple- 
mented with 1 g/1 D-glucose (DPBSG) and subse- 
quently exposed, unless indicated otherwise, at 
37°C for 30 rain to 500 gl of the peptide solutions 
in DPBSG. Thereafter, the incubation solutions were 
removed, the cells were washed two times with ice- 
cold PBS, incubated with 500 gl of ice-cold PBS and 
treated with diazotized 2-nitroaniline as described 
previously [14] in order to modify any surface bound 
peptide. In brief, to 400 gl ethanol/water 1:1 v/v 
containing 2-nitroaniline (0.06 M) and HC1 
(0.125 M), 50 gl 0.6 M NaNO2, were added. After 
standing for 5 min at ambient emperature, 10 gl of 
this reagent was added to the ice-cold PBS covering 
the cell layer and allowed to react for 10 min at 0°C. 
After aspiration of the diazo reagent, the cells were 
washed two times with ice-cold PBS and finally lysed 
with 0.2 ml 0.1% Triton X-100 containing 10 mmol/1 
trifluoroacetic acid for 2 h at 0°C. The resulting ly- 
sate was used for HPLC analysis and for protein 
determination according to Bradford [15]. The aver- 
age protein content of 106 cells assayed by this meth- 
od was 110 gg. The average volume of the cells was 
determined to be 1.4 pl by means of a Coulter-ZM 
counter (Coulter Electronics, Luton, UK). 
In each experiment, cells in triplicate were exposed 
in parallel for 30 min at 37°C to 1.8 gM I to 
obtain reference values for normalization. The basis 
values for normalization, determined in eight inde- 
pendent uptake experiments were 50 + 31, 56 + 29 
and 155 + 37 pmol/mg protein for the metabolized, 
intact and membrane inserted peptide fractions, re- 
spectively. 
To measure the pore-forming propensity of the 
peptides, the cells were pre-exposed to a 12 ~tM sol- 
ution of fluorescein diacetate in DPBSG (containing 
0.5% DMSO) for 15 min at 37°C. After aspiration of 
the fluorescein diacetate solution, the cells were 
rinsed four times with DPBSG 37°C and then ex- 
posed to the peptides. Since for the control cells a 
noticeable xport of the fluorescein generated within 
the cells was also observed (half-life time at 37°C, 
9 min) an exact time regime was required for the 
wash steps to warrant reliability. 
2.3.1. HPLC analysis 
HPLC was performed using a Bischoff HPLC-gra- 
dient system (Leonberg, Germany) with a Polyencap 
A 300, 5 ktm column (250 x 4 mm i.d.), precolumns 
containing the same adsorbent and a Fluorescence 
HPLC Monitor RF-551 (Shimadzu). 
Up to 200 ~tl of the cell lysates was passed through 
a precolumn containing 60 mg of Polyencap (A300, 
5 ~tm), which was subsequently connected to the 
HPLC system. The elution was carried out with 
0.01 M TFA (A) and acetonitrile/water 9:1 (B) at a 
flow rate of 1.0 ml/min with gradients of 30-45% B 
(0-10 min) and 45-80% B (15-20 min) for peptides 
and 30-60% B (0-15 min) and 60-80% B (15-20 min) 
for peptide conjugates. Quantitation was performed 
by fluorescence measurement at 520 nm after excita- 
tion at 445 nm by means of calibration lines obtained 
with the parent peptides under identical conditions. 
For unknown metabolites a 2-fold molar fluores- 
cence intensity as found during HPLC for I was 
used for quantitation, based on the generally 2-3- 
fold higher molar fluorescence intensities observed 
for HPLC peaks of characterized derivatives of I, 
with lower structure forming propensity. 
2.3.2. Confocal aser scanning microscopy (CLSM)  
104 cells were plated on 22x22 mm coverslips 
glued (with silicones RTV 615A/615B, Hellermann, 
Pinneberg) above the hole (15 mm diameter) of 
punched plastic Costar culture dishes (35 mm diam- 
eter; Tecnomara Deutschland, Frankfurt/Main) and 
cultured, exposed to peptides and washed as de- 








130 J. Oehlke et al./Biochimica et Biophysica Acta 1414 (1998) 127-139 
' ' ' 'o 0 5 10 15 2 25 
nlin 
Fig. 1. HPLC chromatogram of the Triton X-100 lysate of AEC exposed for 30 min at 37°C to 1.8 ~tM I, without (thin line; injection 
of 100 ~tl cell lysate containing 25 I.tg cell protein) and with treatment with diazotized 2-nitroaniline (thick line; to facilitate compari- 
son with the former experiment, in this case 200 ~tl cell lysate containing 46 Ixg cell protein were injected). Peaks correspond to: A, in- 
trinsic cell fluorescence; B, metabolite (FLUOS-lysine), generated intracellularly; C, intact I; D, peptide portion modified partially by 
diazotized 2-nitroaniline. 
cells with 200 I.tl PBS, microscopy was performed 
within 10 min at room temperature using an LSM 
410 invert confocal laser scanning microscope (Zeiss, 
Jena, Germany). Excitation was performed at 488 
(FLUOS) or 364 nm (dansyl) by means of an ar- 
gon-krypton or an argon-ion laser and a dichroitic 
mirror FT 510 or FT 395 for wavelength selection, 
respectively. Emission was measured upon 515 or 
420 nm with cut-off filters LP 515 and LP 420, re- 
spectively, in front of the detector. For optical sec- 
tioning in z-direction, 16 frames with a thickness of 
1 ktm were made. 
3.  Resu l ts  
3.1. Discrimination of cell associated I into surface 
bound, membrane inserted and internalized 
portions 
After exposure of AEC to the fluorescein labeled 
(t-helical amphipathic 18-mer peptide FLUOS- 
KLALKLALKALKAALKLA-NH2 (I) high 
amounts of intact peptide accompanied by small 
quantities of fluorescent peptide fragments were de- 
tected in the lysates of the washed ceils (Fig. 1). 
To obtain quantitative information about the por- 
tions of peptide associated with the plasma mem- 
brane and that actually internalized, we treated the 
peptide exposed, washed cells with diazotized 2-ni- 
troaniline, a procedure shown previously to modify 
surface bound primary amino compounds, while 
leaving those within the cell intact [14]. This reagent 
has the crucial advantage of being highly reactive 
even at 0°C, so that bias of the results by counter- 
acting efflux processes, strongly attenuated or sup- 
pressed at this temperature, is minimized. 
About 20% of the cell associated peptide proved 
to be inaccessible to the diazo reagent and therefore 
appeared to be internalized (Fig. 1). Related to the 
peptide concentration i  the incubation solution this 
amount represents a 4-5-fold enrichment of the 
peptide within the cell, taking into account the 
100 pmol/mg protein internalized peptide obtained 
after exposing AEC to 1.8 p.M I for 30 min at 
37°C (see below) in conjunction with the ratio of 








0 -~ " ~  
0 2 4 6 8 10 12 14 16 
IJM 
o MTT; % of control 
• Fluoresceinl % of control 
• lactate dehyctrogenase releasedl % of total 
Fig. 2. MTT reactivity, fluorescein content (generated from in- 
ternalized fluorescein diacetate) and liberation of lactate dehy- 
drogenase from AEC after exposure for 30 min at 37°C to dif- 
ferent concentrations of I. Each point represents the mean of 
three samples + S.D. (S.D. of LDH release in all cases remained 
below 10% of the mean.) 
110 p.g proteirdl06 cells and the cell volume of 1.4 pl 
(see Section 2. 
About 50% of the cell associated peptide disap- 
peared from the HPLC chromatogram after treat- 
ment with diazotized 2-nitroaniline. Since treatment 
of I with diazotized 2-nitroaniline in control experi- 
ments (aqueous olutions of comparable concentra- 
tion or I adsorbed onto the surface of empty cell 
culture plates, which is resistant o washing with 
PBS and desorbable with 0.1% Triton X-100) ren- 
dered the peptide completely undetectable; this por- 
tion was attributed to surface bound peptide. The 
inability to detect any modified peptide derivatives 
is very likely accounted for by the strong retention 
of highly hydrophobic deamination derivatives on 
the stationary phase of the HPLC column or on 
the plastic of the wells. 
About 30% of the cell associated peptide was 
transformed by the diazo reagent into moderately 
more hydrophobic modification products, appearing 
in the HPLC chromatogram immediately after the 
intact peptide (Fig. 1). In contrast o the complete 
modification observed in the control experiments, in
this case, only a part of the five side-chain amino- 
groups of I appeared to have been modified, suggest- 
ing partial protection against the attack of the re- 
agent. Most likely this protection effect appears to 
be interpretable by an insertion of this peptide frac- 
tion into the plasma membrane. 
Apart from the intact peptide, a further fluorescent 
fragment, assigned by electrospray-mass pectros- 
copy to FLUOS-lysine, remained unaffected by di- 
azotized 2-nitroaniline (Fig. 1). This derivative rep- 
resents an additional portion of the internalized 
peptide after metabolization i the cell throughout 
the incubation period. Generation by surface bound 
peptidases followed by internalization can be dis- 
counted as the cause of its appearance in the cell 
lysate by its absence in the incubation solution. Gen- 
eration of this metabolite after the incubation period 
by peptidases liberated during cell lysis can be ex- 
cluded because exposure of the intact peptide to 
cell lysates after Triton X-100/0.1% TFA lysis (see 
Section 2 did not give rise to this product. 
After analogous exposure of the cells to FLUOS- 
KALKLKLALALLAKLKLA-NH2 (II) an analog 
of I with virtually identical amino acid composition 
and comparable high helicity, but lacking amphipa- 
thicity [16], the subsequent treatment with diazotized 
2-nitroaniline rendered the cell associated peptide 
completely undetectable (not shown). In the absence 
of the diazo reagent, II was found in the cell lysate to 
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Fig. 3. Cell-associated peptide, showing fractions remaining in- 
tact, metabolized within the cell interior and partially modified 
by diazotized 2-nitroaniline r spectively, after exposing AEC for 
different times at 37°C to 1.8 ~tM I, and after re-exchange for
30 min at 37°C of cells preloaded for 60 min as described 
above. Each bar represents the mean of three samples_+ S.D. 
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Fig. 4. Cell-associated peptide, showing fraction inaccessible to 
diazotized 2-nitroaniline (sum of intact and metabolized pep- 
tide) and fraction modified partially by this reagent, respec- 
tively, after exposing AEC to different concentrations of I for 
30 min at 37°C. Each point represents the mean of three sam- 
ples + S.D. 
cating comparable surface binding for I and II, while 
also confirming the efficiency of the diazo regent. 
In contrast o the above described results, acid 
wash of the peptide loaded cells (5 min at 0°C with 
HAc/NaC1, 0.2 M/0.05 M), a procedure commonly 
used to strip surface bound peptides [17], failed to 
remove I from the cell surface (loss < 5%; not 
shown). 
3.2. Membrane toxicity of I 
To minimize possible additional influences we 
omitted BSA and thiorphan additives from the incu- 
bation solution in contrast o our previous experi- 
ments [8]. Initial indications of perforation of the 
plasma membrane were detected at 4 ktM peptide 
by impaired Trypan blue exclusion (not shown) as 
well as by liberation of both LDH and fluorescein 
(generated from pre-incorporated fluorescein diace- 
tate) (Fig. 2). Concomitantly, the viability estimated 
by the MTT method [18] became impaired (Fig. 2). 
3.3. Concentration- and time-dependence of the 
internalization of I 
The internalization of I, represented bythe peptide 
fractions inaccessible to the diazo reagent proceeded 
roughly linearly throughout a period of 60 min (Fig. 
3). Longer incubation periods were precluded be- 
cause of increasing interference due to enzymatic 
cleavage of I within the incubation solution. Distinct 
from the internalization, the insertion of I into the 
plasma membrane, measured as the fraction prone to 
modification by diazotized 2-nitroaniline, showed no 
significant ime dependence within 10-60 min and 
approached an equilibrium at least at about 30 min 
(Fig. 3), suggesting that the two processes are inde- 
pendent of one another. 
Generation of metabolites, represented by the pre- 
dominant FLUOS-lysine (see above), exhibited a de- 
layed onset, suggesting that the peptide reached the 
140 
I •metabolized peptide 
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Fig. 5. Sum of the fractions of cell-associated peptide and pep- 
tide fragments inaccessible to diazotized 2-nitroaniline after ex- 
posing AEC for 30 min at 37°C to 1.8 ~M I dissolved in 
DPBSG (control and NEM, respectively), in DPBSG adjusted 
with HC1 to pH 6.0 (pH 6.0), in sodium-flee buffer (DPBSG 
with NaC1 and phosphates replaced by 137 mM choline chlor- 
ide and 10 mM HEPES, respectively), in DPBSG without calci- 
um (absence of calcium), in DPBS containing 25 mM 2-deoxy- 
glucose/10 mM sodium azide (DOG/sodium azide) or 20 ~tM 
monensin (monensin) or 20 p,M vincristine (vincristine), respec- 
tively, and in DPBSG at 0°C. Before exposure to the peptide, 
the cells used for the NEM, DOG/sodium azide and 0°C ex- 
periments were incubated at 37°C for 5 min in DPBSG contain- 
ing 1 mM N-ethylmaleimide and subsequently rinsed three 
times with DPBSG (NEM) or incubated for 60 min at 37°C in 
DPBS containing 25 mM 2-deoxyglucose/10 mM sodium azide 
(DOG/sodium azid¢) or in DPBSG for 60 min at 0°C respec- 
tively. Each bar represents the mean of three samples + S,D. 
(calculated from the S.D. values of both components). The dif- 
ferences between the respective controls and the asterisk labeled 
bars are statistically significant at P-< 0.05 (Student's t-test). 
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metabolizing compartment only after > 10 min. To- 
gether with a perinuclear enrichment of fluorescence 
observed by CLSM [8], and the absence of any effect 
of raising the lysosomal pH by the use of chloro- 
quine (see below), our data implicate the endoplas- 
mic reticulum as being the metabolizing compart- 
ment. 
Within the concentration range 1-5 pM the uptake 
of I rose nearly linearly (Fig. 4). At higher concen- 
trations the amount of cell associated peptide and 
also the ratio of the peptide modified by diazotized 
2-nitroaniline to that remaining unmodified increased 
overproportionally (Fig. 4), indicating increased ac- 
cess to the cell interior for both peptide and diazo 
reagent due to perforation of the plasma membrane. 
Peptide binding to internal cell structures proved suf- 
ficiently avid to resist the wash process, as observed 
for the peptide portion inserted into the plasma 
membrane. Such avid binding to plasma membrane 
and intracellular structures might explain the rela- 
tively small loss of both the internalized (intact and 
metabolized) and membrane inserted peptide frac- 
tions found in efflux experiments with peptide loaded 
intact cells (Fig. 3). Addition of proteins (albumin, 
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Fig. 7. Cell-associated peptide, showing fractions remaining in- 
tact, metabolized within the cell interior and partially modified 
by diazotized 2-nitroaniline r spectively, after exposing AEC for 
30 min at 37°C to 4.5 pM I in DPBS containing, 0.4, 2, 10% 
fetal calf serum (FCS), 10% FCS dialyzed at a molecular weight 
cut-off of 50 kDa (MWCO 50000) and 1% bovine serum albu- 
min (BSA), respectively. Each bar represents the mean of three 
samples _+ S.D. 
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Fig. 6. Fraction of cell-associated peptide inaccessible to diazo- 
tized 2-nitroaniline after exposing AEC for 30 min at 37°C to 
1.8 pM III (all-o enantiomer of I) dissolved in DPBSG (control 
and NEM, respectively), in DPBSG adjusted with HC1 to pH 
6.0 (pH 6.0), in sodium-free buffer, in DPBS containing 25 mM 
2-deoxyglucose/10 mM sodium azide (DOG/sodium azide), and 
in DPBSG at 0°C (conditions for pretreatment as outlined in 
the legend of Fig. 5). Each bar represents the mean of three 
samples+ S.D. The differences between the respective controls 
and the asterisk labeled bars are statistically significant at 
P-< 0.05 (Student's t-test). 
3.4. Effects of factors known to affect endocytosis or 
transport protein function on the cellular uptake 
of 1 
To gain insights into the mode of the cellular up- 
take of I, we varied temperature, nergy supply, pH 
and ionic composition of the incubation buffer and 
compared the uptake behavior of I with that of its 
all-D-analog III. Furthermore, to assess the possible 
contributions of endocytic processes and mdrp- [19] 
and MRP-like [20] and large anion transporters [21] 
which are thought o mediate peptide transport [22- 
24], the influence of additives known to affect endo- 
cytosis or to inhibit mdrp or MRP and the large 
anion transporter respectively, was examined. 
Fig. 5 shows the effects of energy depletion, low- 
ered temperature and the above-mentioned reagents 
upon internalization of I into the cell. The respective 
membrane inserted portions (partially modified by 
the diazo reagent) did not differ significantly and 
are not shown. Different effects are apparent on 
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Fig. 8. Cell-associated peptide, showing fractions remaining in- 
tact, metabolized within the cell interior and partially modified 
by diazotized 2-nitroaniline, respectively, after exposing various 
cell types from different species and organs to 1.8 ~tM I for 30 
min at 37 or at 0°C, respectively. Before exposure to the pep- 
tide, the cells were incubated for 60 min at 37 or at 0°C in 
DPBSG. Additionally, the results of exposing AEC to FLUOS- 
labeled Ant-P-peptide [3], a natural plasma membrane perme- 
able sequence, using the same conditions are shown. Each bar 
represents the mean of three samples + S.D. The differences be- 
tween the respective controls and the asterisk-marked bars are 
statistically significant at P ~ 0.05 (Student's t-test). 
both the total quantity of internalized peptide (sum 
of intact and metabolized peptide portions) and on 
the metabolized portion, indicating distinct modes 
for crossing the plasma membrane and entering the 
metabolizing compartment (Fig. 5). With the excep- 
tion of calcium depletion and vincristine treatment, 
the total quantity of internalized I was affected sig- 
nificantly in all cases. Most of the incubation varia- 
tions applied in Fig. 5 (energy depletion, reduced 
temperature, lowering of both the external and, after 
monensin treatment, he internal pH, hyperosmolar 
sucrose, NEM) are commonly regarded as inhibiting 
either clathrin-dependent [25-27] or cavaeolae-medi- 
ated endocytosis [28,29]. Potassium depletion, known 
to inhibit clathrin-dependent docytosis [26,30], el- 
evation of lysosomal pH by 100 pM chloroquine 
[31], disturbance of endosomal transport by 5 ~tM 
Brefeldin A [32], addition of DNP-S-glutathione 
(100 ~tM), an inhibitor of MRP and the large anion 
transporter MOAT [20,21] and depletion of magne- 
sium had no effect upon internalization and metab- 
olization of I (not shown). 
With the all-D derivative of I (designated III), com- 
parable cellular uptake to that of the parent peptide 
was achieved (Fig. 6), ruling out sterically specific 
interactions to account for internalization. Moderate 
differences between the uptake behavior of both 
enantiomers became apparent after alteration of the 
incubation conditions (Figs. 5 and 6), suggesting that 
the involved mechanisms participate to different de- 
grees in their translocation. As expected, only intact 
peptide, i.e. no cleavage product, was found in either 
incubation solution or cell lysate in the case of III. 
3.5. Influence of serum proteins on the cellular uptake 
of I 
Since binding to serum proteins might alter the 
cellular uptake, we exposed AEC to I in the presence 
of different concentrations of FCS and BSA (Fig. 7). 
Surprisingly, at low concentrations, FCS seems to 
elevate the quantity of cell associated peptide in all 
fractions. At higher concentrations, the metabolized 
peptide fraction was more strongly depleted than 
were the other two fractions (Fig. 7). Both observa- 
tions indicate that simple adsorption of peptide to 
serum proteins is unlikely. The presence of 1% 
BSA, expected to exert at least comparable adsorp- 
tion effects had no significant influence (Fig. 7; un- 
detectable at BSA < 0.5%) supporting the latter no- 
tion and suggesting that activation and inhibition, 
respectively, should be taken into consideration i  
any interpretation. 
To obtain information about the molecular size of 
the FCS components which might influence the cel- 
lular uptake of I we performed ialysis using cellu- 
lose ester membranes with molecular weight cut-offs 
(MWCO) of 10 and 50 kDa. After dialysis with the 
MWCO 10 kDa membrane, the inhibitory effect of 
FCS remained unchanged, excluding a role for com- 
ponents of less than 10 kDa. A comparable inhibi- 
tory effect was observed for FCS dialyzed with a 
MWCO 50 kDa membrane (Fig. 7), suggesting that 
the predominant portion of the putative inhibitory 
serum components are protein(s) of > 50 kDa. 
J. Oehlke et al./ Biochimica et Biophysica Acta 1414 (1998) 127-139 135 
3.6. Comparison of the cellular internalization f I 
with that of the Ant-P peptide and uptake of I 
into other cell types 
For comparison, AEC were exposed to the Ant-P 
peptide, a successfully established natural vector pep- 
tide [3,33], using the same conditions. A principally 
similar uptake behavior was found for I and this 
natural peptide at 37°C. As a noticeable difference, 
the ratio between the peptide fraction being accessi- 
ble to the membrane impermeable diazo reagent and 
the internalized peptide was enhanced in the latter 
case (Fig. 8). 
To rule out the possibility that the observed up- 
take behavior might primarily reflect peculiarities of 
the cell line used, we exposed endothelial cells from 
other species, as well as other cell types to I. In all 
cases, we found an extensive uptake of I, with sig- 
nificant variability regarding both uptake and metab- 
olizing activity (Fig. 8). A considerable portion of the 
uptake, however, was retained at 0°C in all cases 
(Fig. 8), indicating that non-endocytic mechanisms 
were generally operative. Except in the case of 
AEC and human nerve cells, metabolization of the 
peptide also was observed at 0°C (Fig. 8), suggesting 
the transport into the metabolizing compartment to 
be non-endocytic in these cells. In distinction to 
AEC, in the lysates of the other cell types, fluorescent 
metabolites exhibiting retention times between that 
of FLUOS-lysine and intact I were observed. The 
metabolites found within the cell lysates were not 
detected in the incubation solution and therefore 
must have been generated within the cell. Trypan 
blue exclusion revealed no sign of membrane damage 
under the conditions used. 
3.7. Cellular uptake of I tagged by disulfide bridges to 
negatively and positively charged short peptides 
To assess the ability of I to serve as vector for 
introducing polar compounds of biological interest 
into the cell interior, we examined the cellular uptake 
of I tagged by disulfide bridges to negatively and 
positively charged short peptides by CLSM (Fig. 
9). The cargo peptides of potential biological interest 
used were pYEEWE, whose isoleucine in place of a 
tryptophan containing analog exhibits affinity to the 
SH2 domains of various signal proteins [34,35] and 
Fig. 9. CLSM image of a 1-~tm-thick central horizontal optical 
section trough AEC pre-exposed for 30 min at 37°C to 1 ~M 
of FLUOS-GCKLALKLALKALKAALKLA-NH2 tagged by 
disulfide bridges to AcCpYEEWE-NH2 (upper panel, x 1000, 
FLUOS mode) or DansyI-CPKKKRKV-NH2 (lower panel, 
x 1600, dansyl mode). 
PKKKRKV, the nuclear localization sequence of the 
SV40 large T antigen [36]. For generating the con- 
jugates, both components were extended N-termi- 
nally with cysteine or a G-C elongation (I) and a 
disulfide bridge was formed using Ellman's reagent 
(see Section 2). Analogous attempts to generate a 
disulfide bridged conjugate with a 15-mer oligonu- 
cleotide failed, since we were unable to isolate a 
water soluble reaction product, probably due to ag- 
gregation. 
As CLSM revealed, the peptide conjugates were 
taken up into the cytosol similarly to I; the conjugate 
bearing the SV40 nuclear localization sequence 
reached into the nucleus (Fig. 9). No enzymatic 
cleavage was detectable by subsequent HPLC exami- 
nation of both incubation solution and cell lysate, 
indicating that the peptide conjugates had been in- 
ternalized in the intact form. 
4. Discussion 
In a previous study, we described an extensive, 
amphipathicity-dependent uptake into bovine aortic 
endothelial cells (AEC) of the m-helical amphipathic 
136 3". Oehlke et al./Biochimiea et Biophysica Acta 1414 (1998) 127-139 
model peptide I (FLUOS-KLALKLALKALKAAL- 
KLA-NH2) [8]. The observation that the quantity of 
cell associated I was only moderately affected by low- 
ering the incubation temperature to 0°C and energy 
depletion suggested a non-endocytic mechanism and 
an analogy with the recently reported cellular uptake 
of natural structure forming peptides proceeding by 
a non-endocytic, but still unidentified pathway [3-5]. 
Detailed HPLC examination i to the mode of up- 
take of I in the present study, avoiding interference 
between plasma membrane bound and internalized 
peptide fractions, indicated participation of multiple, 
energy-dependent a d -independent mechanisms. A 
comparable uptake behavior was observed for the 
all-D analog of I (III), indicating non-specificity of 
the involved transport processes. A similar uptake 
behavior has been reported by Derossi et al. [37] 
for the Ant-P-peptide and its inverso and retro-inver- 
so derivatives. Analogy between the uptake behavior 
of I and the Ant-P peptide became apparent also 
after direct comparison of the internalization of 
both peptides into endothelial cells performed in 
the present study. 
About 50% of the uptake of I was found to be 
retained at 0°C and after energy depletion, indicating 
that this peptide fraction, at least, had been internal- 
ized in a non-endocytic manner. Since the aforemen- 
tioned natural peptides have been exploited success- 
fully for delivering covalently tagged oligonucleotides 
and peptides directly into the cytosol with the crucial 
advantage of bypassing the endosomal compartment 
[3-5,33,37], this at least partially non-endocytic cel- 
lular uptake of I is of particular interest. 
The mechanism of this non-endocytic entry into 
the cell interior remains elusive. Any pore-forming 
activity of I could be eliminated below concentra- 
tions of 2 ~tM as shown by Trypan blue exclusion, 
LDH release and capture within the cell of fluores- 
cein generated from internalized fluorescein diace- 
rate. The most attractive alternative interpretations 
are either direct penetration into or across lipidic 
areas of the plasma membrane or facilitated iffu- 
sion. Crossing of lipid bilayers has been repeatedly 
reported for helical amphipathic peptides e.g. mito- 
chondrial presequences [38], so this possibility cannot 
be ruled out. The repeatedly reported transfer across 
the plasma membrane of conjugates between such 
peptides and relatively high molecular weight, nega- 
tively charged polar entities, e.g. antisense oligonu- 
cleotides [4,33], however, appear inexplicable by such 
a mechanism. That facilitated iffusion plays a sig- 
nificant role, on the other hand, must remain hypo- 
thetical, since an interaction of amphipathic peptides 
with proteinaceous membrane transporters would be 
required; such interactions have, as yet, not been 
demonstrated. 
Interpretation of the energy-dependent portion of 
the uptake of I would normally, according to the 
established knowledge, imply an endocytic mecha- 
nism. Our results, however, provide arguments 
against as well as in favor of an endocytic mode. 
In particular, the complete lack of cellular uptake 
of II, the non-amphipathic analog of I exhibiting 
identical positive charges, argues strongly against a 
significant contribution from endocytosis. If adsorp- 
tive endocytosis were to be the predominant mecha- 
nism for the uptake of I, then peptide II also should 
be internalized to a clearly measurable degree, since 
this derivative has also been found to be adsorbed 
extensively to the cell surface (to about 30% to that 
of cell associated I) [8]. Moreover, the high quantity 
of internalized I contraindicates an endocytic mech- 
anism, considering that this amount corresponds to 
an enrichment within the cell interior of up to a 
10-fold of the externally provided peptide and that 
the volume of the endocytic ompartment amounts 
to maximally 10% of the total cell volume [25,39]. 
Further arguments against the significant involve- 
ment of endocytosis are the absence of any effect 
of potassium depletion, previously reported to char- 
acteristically affect clathrin-dependent endocytosis 
[30], and the significant inhibitive effect of sodium 
depletion. 
On the other hand, the strong effects of energy 
depletion, lowered temperature, alteration of both 
the internal and external pH, the presence of hyper- 
osmolar sucrose and pretreatment with NEM are 
commonly considered to be characteristic of cla- 
thrin-dependent [25-27] or cavaeolae-mediated en o- 
cytosis [28,29], respectively. It should be noted, how- 
ever, that the effects above might also be explainable 
by translocation events mediated by carrier proteins 
or proceeding across protein channels, which have 
often been found to exhibit pH- and energy-depend- 
ence [4042]. In the same way, the effect of hyper- 
osmolar sucrose might be interpreted as the effect of 
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membrane shrinking due to the hyperosmolar stress 
[43]. 
Alternatively to an endocytic uptake, a transloca- 
tion by proteinaceous import machineries might be 
taken into consideration. Such a possibility is sup- 
ported by structural similarities between I and helical 
amphipathic leader sequences initiating an energy-de- 
pendent transport of various proteins across the 
membranes of ER, mitochondria nd nuclei of eu- 
karyotic cells [44-46] and the cell membrane of pro- 
karyotes [47]. The inhibitive effects observed on the 
internalization of I of proteinaceous FCS compo- 
nents appear reconcilable with the action of such 
putative protein import machineries. However, the 
existence of such transport facilities has not yet 
been demonstrated for plasma membranes of mam- 
malian cells, mainly for technical reasons as e.g. Isen- 
man et al. have suggested [48]. 
A non-endocytic mode of uptake for I is further 
implied by the close analogy between the internaliza- 
tion of I and that of smaller peptides (tetra- to un- 
decamer); these have been found previously to cross 
mammalian plasma membranes extensively and un- 
specifically by energy-dependent and -independent 
unknown mechanisms [9]. This analogy tempts to 
assume a common mode for the uptake of both 
types of peptide. In this case, however, helical 
properties would not be decisive for the actual trans- 
port step, as the small peptides are unable to adopt 
helical structures. Support for such an interpretation 
is provided by the recent study of Vives et al. [7], 
revealing that non-helical short basic sequences are 
responsible for the membrane permeability of the 
TAT-peptide. That helicity is not an essential struc- 
tural requirement for peptides to cross biological 
membranes is also suggested by the recently reported 
cellular internalization of various [~-sheet forming 
peptides [6,49]. 
Such interpretation, however, would mean that the 
here found extensive uptake of I only resembles an 
avid binding to intracellular structures subsequent to
internalization rather than increased membrane pas- 
sage. 
Based on the data currently available, an unequiv- 
ocal decision for either of the mechanisms discussed 
appears impossible. Additional studies to address 
these questions are under way. 
The ability of I to cross the plasma membrane was 
retained after an N-terminal glycine-cysteine elonga- 
tion and subsequent coupling of acidic or basic 5-7 
mer peptide sequences, demonstrating the distinct 
possibility of using I-like model peptides as vectors 
for mediating the passage of polar bioactive com- 
pounds across the plasma membrane of mammalian 
cells generally. Moreover, differences with respect o 
efficiency of uptake and rate of metabolic breakdown 
observed with various cell types promise cell and 
tissue selectivity utilizing such vector peptides. 
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